Hydrogen Bonding (Base Pairing) in Antiviral Activity

Overview

Journal Viruses

Publisher MDPI

Specialty Microbiology

Date 2023 May 27

PMID 37243232

Authors

Erik De Clercq

Affiliations

Soon will be listed here.

Abstract

Base pairing based on hydrogen bonding has, since its inception, been crucial in the antiviral activity of arabinosyladenine, 2'-deoxyuridines (i.e., IDU, TFT, BVDU), acyclic nucleoside analogues (i.e., acyclovir) and nucleoside reverse transcriptase inhibitors (NRTIs). Base pairing based on hydrogen bonding also plays a key role in the mechanism of action of various acyclic nucleoside phosphonates (ANPs) such as adefovir, tenofovir, cidofovir and O-DAPYs, thus explaining their activity against a wide array of DNA viruses (human hepatitis B virus (HBV), human immunodeficiency (HIV) and human herpes viruses (i.e., human cytomegalovirus)). Hydrogen bonding (base pairing) also seems to be involved in the inhibitory activity of Cf1743 (and its prodrug FV-100) against varicella-zoster virus (VZV) and in the activity of sofosbuvir against hepatitis C virus and that of remdesivir against SARS-CoV-2 (COVID-19). Hydrogen bonding (base pairing) may also explain the broad-spectrum antiviral effects of ribavirin and favipiravir. This may lead to lethal mutagenesis (error catastrophe), as has been demonstrated with molnutegravir in its activity against SARS-CoV-2.

References

Bhatia H, Singh H, Grewal N, Natt N . Sofosbuvir: A novel treatment option for chronic hepatitis C infection. J Pharmacol Pharmacother. 2014; 5(4):278-84. PMC: 4231565. DOI: 10.4103/0976-500X.142464. View

Furman P, Fyfe J, St Clair M, Weinhold K, Rideout J, Freeman G . Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci U S A. 1986; 83(21):8333-7. PMC: 386922. DOI: 10.1073/pnas.83.21.8333. View

Wang Y, Yuan C, Xu X, Chong T, Zhang L, Cheung P . The mechanism of action of T-705 as a unique delayed chain terminator on influenza viral polymerase transcription. Biophys Chem. 2021; 277:106652. DOI: 10.1016/j.bpc.2021.106652. View

Kaufman H, HEIDELBERGER C . THERAPEUTIC ANTIVIRAL ACTION OF 5-TRIFLUOROMETHYL-2'-DEOXYURIDINE IN HERPES SIMPLEX KERATITIS. Science. 1964; 145(3632):585-6. DOI: 10.1126/science.145.3632.585. View

Mackman R, Hui H, Perron M, Murakami E, Palmiotti C, Lee G . Prodrugs of a 1'-CN-4-Aza-7,9-dideazaadenosine -Nucleoside Leading to the Discovery of Remdesivir (GS-5734) as a Potent Inhibitor of Respiratory Syncytial Virus with Efficacy in the African Green Monkey Model of RSV. J Med Chem. 2021; 64(8):5001-5017. DOI: 10.1021/acs.jmedchem.1c00071. View

Whitley R, Chien L, Dolin R, Galasso G, Alford Jr C . Adenine arabinoside therapy of herpes zoster in the immunosuppressed. NIAID collaborative antiviral study. N Engl J Med. 1976; 294(22):1193-9. DOI: 10.1056/NEJM197605272942201. View

Gentile I, Borgia F, Zappulo E, Buonomo A, Spera A, Castaldo G . Efficacy and Safety of Sofosbuvir in the Treatment of Chronic Hepatitis C: The Dawn of a New Era. Rev Recent Clin Trials. 2013; 9(1):1-7. DOI: 10.2174/1574887108666131213120354. View

Mitsuya H, Weinhold K, Furman P, St Clair M, Lehrman S, Gallo R . 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc Natl Acad Sci U S A. 1985; 82(20):7096-100. PMC: 391317. DOI: 10.1073/pnas.82.20.7096. View

SANGER F, Nicklen S, Coulson A . DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977; 74(12):5463-7. PMC: 431765. DOI: 10.1073/pnas.74.12.5463. View

10.

De Clercq E, Descamps J, Verhelst G, Walker R, Jones A, Torrence P . Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus. J Infect Dis. 1980; 141(5):563-74. DOI: 10.1093/infdis/141.5.563. View

11.

Waters M, Warren S, Hughes C, Lewis P, Zhang F . Human genetic risk of treatment with antiviral nucleoside analog drugs that induce lethal mutagenesis: The special case of molnupiravir. Environ Mol Mutagen. 2022; 63(1):37-63. DOI: 10.1002/em.22471. View

12.

Watson J, Crick F . Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature. 1953; 171(4356):737-8. DOI: 10.1038/171737a0. View

13.

De Clercq E, Descamps J, DE SOMER P, Barr P, Jones A, Walker R . (E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent. Proc Natl Acad Sci U S A. 1979; 76(6):2947-51. PMC: 383727. DOI: 10.1073/pnas.76.6.2947. View

14.

Leyssen P, Balzarini J, De Clercq E, Neyts J . The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase. J Virol. 2005; 79(3):1943-7. PMC: 544097. DOI: 10.1128/JVI.79.3.1943-1947.2005. View

15.

Shannon A, Selisko B, Le N, Huchting J, Touret F, Piorkowski G . Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis. Nat Commun. 2020; 11(1):4682. PMC: 7499305. DOI: 10.1038/s41467-020-18463-z. View

16.

Kaufman H . Clinical cure of herpes simplex keratitis by 5-iodo-2-deoxyuridine. Proc Soc Exp Biol Med. 1962; 109:251-2. DOI: 10.3181/00379727-109-27169. View

17.

Whitley R, Soong S, Dolin R, Galasso G, Chien L, Alford C . Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study. N Engl J Med. 1977; 297(6):289-94. DOI: 10.1056/NEJM197708112970601. View

18.

Baba M, Pauwels R, Herdewijn P, De Clercq E, Desmyter J, Vandeputte M . Both 2',3'-dideoxythymidine and its 2',3'-unsaturated derivative (2',3'-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro. Biochem Biophys Res Commun. 1987; 142(1):128-34. DOI: 10.1016/0006-291x(87)90460-8. View

19.

Furuta Y, Takahashi K, Kuno-Maekawa M, Sangawa H, Uehara S, Kozaki K . Mechanism of action of T-705 against influenza virus. Antimicrob Agents Chemother. 2005; 49(3):981-6. PMC: 549233. DOI: 10.1128/AAC.49.3.981-986.2005. View

20.

De Clercq E . New Nucleoside Analogues for the Treatment of Hemorrhagic Fever Virus Infections. Chem Asian J. 2019; 14(22):3962-3968. PMC: 7159701. DOI: 10.1002/asia.201900841. View